Your cart is empty.
Tecan is excited to introduce its We can with Tecan competition, which will recognize the ground-breaking achievements in the field of NGS and reward two winners with their very own MagicPrep™ NGS instruments*. Officially launched today, the competition is open to NGS-based scientists who are either currently conducting – or have recently completed – a cutting-edge research project in a field such as oncology, immunology or infectious diseases. All that is required for entry is a 500-word summary – to be submitted by June 2, 2023 – detailing how NGS has been used to drive real-world benefits, with the winners informed the following month on June 22.
MagicPrep NGS is an automated platform designed to provide busy labs with an extra pair of hands – combining the instrumentation, software, pre-optimized scripts, reagents and consumables needed for NGS library preparation into one simple solution – and the lucky winners will enjoy reduced hands-on time, walkaway automation and push button simplicity*. They will also have their work showcased to the world on Tecan’s website and social channels, providing a platform to share their trailblazing research.
The submissions will be reviewed by a multidisciplinary panel – with expertise in genomics, cellomics and proteomics – and scored on innovation, project design and execution, and the wider impact of the research, with the two highest scoring applications being declared the winners.
To enter this exciting competition, or for more information about eligibility, visit https://studio.tecan.com/wecanwithtecan/magicprep-ngs. Good luck!
For research use only. Not for use in diagnostic procedures.
*The winners will receive a MagicPrep NGS instrument only, no reagents or consumables are included.
Tecan (www.tecan.com) improves people’s lives and health by empowering customers to scale healthcare innovation globally from life science to the clinic. Tecan is a pioneer and global leader in laboratory automation. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments, components and medical devices that are then distributed by partner companies. Founded in Switzerland in 1980, the company has more than 3,000 employees, with manufacturing, research and development sites in Europe, North America and Asia, and maintains a sales and service network in over 70 countries. In 2022, Tecan generated sales of CHF 1,144 million (USD 1,192 million; EUR 1,144 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
For further information: